Article Details

Sierra Oncology (NASDAQ:SRRA) Rating Lowered to Hold at Zacks Investment Research

Retrieved on: 2020-02-08 21:01:27

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (NASDAQ:SRRA) Rating Lowered to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC boosted its stake in Sierra Oncology by 52.5% in the 4th quarter. <b>Acadian Asset Management</b> LLC now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up